Sulfasalazine + Sofosbuvir%2C Velpatasvir%2C And Voxilaprevir Interaction

Majorinteraction on record

Description

BCRP substrate whose exposure may be altered by velpatasvir and voxilaprevir inhibition. Coadministration is not recommended.

Mechanism

BCRP inhibition by velpatasvir and voxilaprevir

Source: NLP:sofosbuvir, velpatasvir, and voxilaprevir